Vital Chemtech Limited (VITAL) — Financial Results

· NSE 🔴 High Importance Neutral
Revenue: ₹126.4 CrNet Profit: ₹1
📢 Key Event
Vital Chemtech reports FY26 results with PAT margin at 0.8%
🔄 What Changed
PAT margin declined to 0.8% from 3.0% YoY; EBITDA margin stable at 7.9%
🔮 What's Next
Management expects subsidiaries to strengthen growth platform and future earnings potential
💡 Investor Takeaway
Strategic investments in subsidiaries are pressuring short-term profits but positioning long-term growth

Vital Chemtech Limited reported FY26 revenue of ₹126.4 crore, down 5.6% YoY, with EBITDA at ₹10.0 crore (-5.6% YoY) and PAT at ₹1.0 crore, reflecting strategic investments in subsidiaries that drove PAT margin compression to 0.8% from 3.0% in FY25, while Q4 FY26 showed stable revenue of ₹35.1 crore and 39.7% YoY EBITDA growth to ₹4.0 crore amid margin expansion.

📄 View Original Announcement (PDF)

About Vital Chemtech Limited (VITAL)

Chemicals · Chemicals & Petrochemicals · Listed on NSE

Market Cap: ₹155.99 Cr

View full VITAL stock details →

📡 Get AI alerts when VITAL files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track VITAL — Free

📊 More VITAL filings

See all VITAL filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when VITAL files new disclosures

Track VITAL filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track VITAL — Free

Free account · 2 AI queries/day